Rebecca has nearly 20 years of experience in clinical trial operations, ranging from post-Proof of Concept (PoC) range-finding studies to pivotal Phase 3 studies. She has led cross-functional teams for global development programs spanning 200+ clinical sites and 700+ patients, focusing seamless workflows towards on-time deliverables. With her track record of success managing clinical operations at Takeda, Biogen, and Clinquest, she brings the optimal blend of big pharma, biotech, and clinical CRO expertise to her current role at Anji.
Rebecca received her B.S. in Advertising from Franklin Pierce College.